Law Practice
Jul. 13, 2009
Team Effort Nets Complex Pharmaceutical Joint Venture
Morrison & Foerster and Wilson Sonsini represented the parties in a newly formed joint venture planning to use "DNA shuffling technology."
By Don J. DeBenedictis
Daily Journal Staff Writer SANTA ANA - Forming a company to create large, complicated pharmaceutical molecules requires a large, complicated deal. Morrison & Foerster assigned 17 of its lawyers worldwide to create a joint venture for client Astellas Pharma Inc. On the other side of the table, Wilson Sonsini Goodrich & Rosati used roughly as many for client Maxygen Inc. The company that the lawyers and clients...
Daily Journal Staff Writer SANTA ANA - Forming a company to create large, complicated pharmaceutical molecules requires a large, complicated deal. Morrison & Foerster assigned 17 of its lawyers worldwide to create a joint venture for client Astellas Pharma Inc. On the other side of the table, Wilson Sonsini Goodrich & Rosati used roughly as many for client Maxygen Inc. The company that the lawyers and clients...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In